BriMindInvest Logo

CRSP (CRSP) Stock Analysis

BriMind AI Score

Proprietary
38
Weak
Price CAGR
14.9%
1Y Return
+22.2%
Analyst Upside
+54.4%
Rev Growth
68.6%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

Compare CRSP with Peers

VRTX vs CRSPVertex vs CRISPR Therapeutics — Rare Disease Franchise
CRSP vs EDITCRISPR Therapeutics vs Editas Medicine — Gene Editing L
NTLA vs CRSPIntellia Therapeutics vs CRISPR Therapeutics — In-Vivo

Unlock the Full CRSP Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 21-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
← Back to Home · Browse All Stock Analysis